Author details

Full Name

Kathleen McCortney

Affiliation

ORCID

Career Start Year

2019

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
38015629	Age-related loss of Notch3 underlies brain vascular contractility deficiencies, glymphatic dysfunction, and neurodegeneration in mice.	J Clin Invest	2024
37104042	Postoperative risk of IDH-mutant glioma-associated seizures and their potential management with IDH-mutant inhibitors.	J Clin Invest	2023
35976058	Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas.	Neuro Oncol	2023
36399711	Determining venous thromboembolism risk in patients with adult-type diffuse glioma.	Blood	2023
37944590	Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.	Nat Med	2023
37919784	Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation results.	Acta Neuropathol Commun	2023
37725593	Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence.	Clin Cancer Res	2023
37886538	LDHA-regulated tumor-macrophage symbiosis promotes glioblastoma progression.		2023
37252795	The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma.	JCI Insight	2023
36993741	Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.	Res Sq	2023
35134075	The efficacy of an unrestricted cycling ketogenic diet in preclinical models of IDH wild-type and IDH mutant glioma.	PLoS ONE	2022
36103817	SerpinB3 drives cancer stem cell survival in glioblastoma.	Cell Reports	2022
36428586	Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts.	Cancers (Basel)	2022
35062028	The Frequency of Focal Cortical Dysplasia-Like Histologic Features Near Adult-Type Diffuse Gliomas.	Journal of Neuropathology and Experimental Neurology	2022
34429075	Longitudinal observational study of boxing therapy in Parkinson's disease, including adverse impacts of the COVID-19 lockdown.	BMC Neurology	2021
33692132	A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma.	Sci Transl Med	2021
33851151	Longitudinal Study of Boxing Therapy in Parkinson's Disease, Including Adverse Impacts of the COVID-19 Lockdown.		2021
33830235	MGMT promoter methylation is associated with patient age and 1p/19q status in IDH-mutant gliomas.	Neuro Oncol	2021
33255632	LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma.	Cancers	2020
32051040	The efficacy of DNA mismatch repair enzyme immunohistochemistry as a screening test for hypermutated gliomas.	Acta neuropathologica communications	2020
31711239	Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas.	Neuro Oncol	2020
30266764	Methylation-dependent Tissue Factor Suppression Contributes to the Reduced Malignancy of IDH1-mutant Gliomas.	Clin Cancer Res	2019